The norepinephrine transporter gene and attention-deficit hyperactivity disorder (Q43938267)

28 November 2017

The norepinephrine transporter gene and attention-deficit hyperactivity disorder (English)

1 reference

attention deficit hyperactivity disorder

28 November 2017

0 references

1 reference

1 reference

1

1 reference

28 November 2017

8

1 reference

28 November 2017

5

Wendy Roberts

1 reference

28 November 2017

Jamie Kroft

2

1 reference

28 November 2017

Yu Feng

3

1 reference

28 November 2017

Karen Wigg

4

1 reference

28 November 2017

Molly Malone

6

1 reference

28 November 2017

Abel Ickowicz

7

1 reference

28 November 2017

Rosemary Tannock

9

1 reference

28 November 2017

James L Kennedy

10

1 reference

28 November 2017

1 April 2002

1 reference

American Journal of Medical Genetics Part A

28 November 2017

1 reference

28 November 2017

114

1 reference

28 November 2017

3

1 reference

28 November 2017

255-259

1 reference

The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder

28 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

Linkage study of catechol-O-methyltransferase and attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

Further evidence from haplotype analysis for linkage of the dopamine D4 receptor gene and attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

Attention-deficit hyperactivity disorder and the gene for the dopamine D5 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

Attention-deficit hyperactivity disorder and the adrenergic receptors alpha 1C and alpha 2C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

A simple salting out procedure for extracting DNA from human nucleated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

Catecholamines in attention-deficit hyperactivity disorder: current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

Molecular cloning and organization of the coding region of the human norepinephrine transporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

The relation of the dopamine transporter gene (DAT1) to symptoms of internalizing disorders in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

An extended transmission/disequilibrium test (TDT) for multi-allele marker loci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

Assignment of the norepinephrine transporter protein (NET1) locusto chromosome 16

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

Linkage study of two polymorphisms at the dopamine D3 receptor gene and attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

Chromosomal mapping of the human gene for the tricyclic antidepressant-sensitive noradrenaline transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

Tourette syndrome and the norepinephrine transporter gene: Results of a systematic mutation screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

Linkage study of the α2A adrenergic receptor in attention-deficit hyperactivity disorder families

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.10193

21 January 2018

Identifiers

DOI

10.1002/AJMG.10193

1 reference

28 November 2017

1 reference